FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016069281> ?p ?o ?g. }

• W2016069281 endingPage "1428" @default.
• W2016069281 startingPage "1424" @default.
• W2016069281 abstract "The need for renal replacement therapy (RRT) either before or after orthotopic liver transplant (OLTX) has been reported to be a poor prognostic indicator for survival. Use of continuous veno-venous hemodialysis (CVVHD) for RRT has been reported in three series of OLTX patients with high 90-day mortality rates of 57-60%. We have examined our patient population to determine the effect of necessity and type of RRT on patient survival after OLTX.We analyzed 1535 OLTX that were performed at our institution from 1985 through 1999, 1037 from 1985 to 1995 (period I) and 498 from 1996 to 1999 (period II). Combined liver-kidney transplants were excluded from analysis. Hospital dialysis unit records and a prospectively maintained database on all OLTX patients served as the source of data. Patients were classified into groups defined on whether or not they received RRT, when they received RRT, and the type of RRT. Groups were compared for preoperative intensive care unit status, time on the waiting list, laboratory variables, 90-day postoperative mortality, 1-year patient survival, and absolute survival.Use of RRT increased from 8.29% in period I to 12.45% in period II, along with increased median waiting times. In period I, patients receiving preoperative RRT had a 90-day mortality (0%) and a 1-year survival (89.5%) almost identical to those patients who never required RRT (1.7% and 90.6%). Patients who developed acute renal failure postoperatively requiring RRT, however, had a 90-day mortality of 28.6% and a 1-year survival of 55%. In period II, patients requiring RRT had a 90-day mortality of 39.7% and a 1-year actuarial survival of 54.5% compared with 6.9% and 88.6% in patients never requiring RRT. Patients treated with CVVHD had a 90-day mortality of 42% compared with 25% in patients treated with hemodialysis alone. However, patients receiving CVVHD both pre- and postoperatively had a 90-day mortality of 27.7% vs. 50% in those patients who only received CVVHD postoperatively. Patients who developed acute renal failure postoperatively, which required RRT, regardless of therapy, had a 1-year survival of only 41.0% compared with a 1-year survival of 73.6% in those patients started on RRT preoperatively, P=0.03.The need for RRT has increased along with waiting time in OLTX patients. Patients developing the need for RRT postoperatively have an increased 90-day mortality and lower 1-year survival with the highest being present in patients receiving CVVHD, which was started postoperatively. These findings may reflect a trend toward a sicker population awaiting OLTX and emphasize the negative impact of renal failure on survival after OLTX." @default.
• W2016069281 created "2016-06-24" @default.
• W2016069281 creator A5009395138 @default.
• W2016069281 creator A5029870788 @default.
• W2016069281 creator A5055449099 @default.
• W2016069281 creator A5063030673 @default.
• W2016069281 creator A5063705635 @default.
• W2016069281 creator A5073266707 @default.
• W2016069281 creator A5078861466 @default.
• W2016069281 date "2001-05-01" @default.
• W2016069281 modified "2023-10-06" @default.
• W2016069281 title "RENAL REPLACEMENT THERAPY AND ORTHOTOPIC LIVER TRANSPLANTATION: THE ROLE OF CONTINUOUS VENO-VENOUS HEMODIALYSIS 1" @default.
• W2016069281 cites W1967634974 @default.
• W2016069281 cites W1973772429 @default.
• W2016069281 cites W1974104493 @default.
• W2016069281 cites W1985729894 @default.
• W2016069281 cites W1992134262 @default.
• W2016069281 cites W2002487190 @default.
• W2016069281 cites W2011102051 @default.
• W2016069281 cites W2028429844 @default.
• W2016069281 cites W2034953095 @default.
• W2016069281 cites W2035065613 @default.
• W2016069281 cites W2083624412 @default.
• W2016069281 cites W2084053749 @default.
• W2016069281 cites W2092738790 @default.
• W2016069281 cites W2136179601 @default.
• W2016069281 cites W2165986402 @default.
• W2016069281 cites W584745171 @default.
• W2016069281 doi "https://doi.org/10.1097/00007890-200105270-00012" @default.
• W2016069281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11391230" @default.
• W2016069281 hasPublicationYear "2001" @default.
• W2016069281 type Work @default.
• W2016069281 sameAs 2016069281 @default.
• W2016069281 citedByCount "140" @default.
• W2016069281 countsByYear W20160692812012 @default.
• W2016069281 countsByYear W20160692812013 @default.
• W2016069281 countsByYear W20160692812014 @default.
• W2016069281 countsByYear W20160692812015 @default.
• W2016069281 countsByYear W20160692812016 @default.
• W2016069281 countsByYear W20160692812017 @default.
• W2016069281 countsByYear W20160692812018 @default.
• W2016069281 countsByYear W20160692812019 @default.
• W2016069281 countsByYear W20160692812020 @default.
• W2016069281 countsByYear W20160692812021 @default.
• W2016069281 countsByYear W20160692812022 @default.
• W2016069281 countsByYear W20160692812023 @default.
• W2016069281 crossrefType "journal-article" @default.
• W2016069281 hasAuthorship W2016069281A5009395138 @default.
• W2016069281 hasAuthorship W2016069281A5029870788 @default.
• W2016069281 hasAuthorship W2016069281A5055449099 @default.
• W2016069281 hasAuthorship W2016069281A5063030673 @default.
• W2016069281 hasAuthorship W2016069281A5063705635 @default.
• W2016069281 hasAuthorship W2016069281A5073266707 @default.
• W2016069281 hasAuthorship W2016069281A5078861466 @default.
• W2016069281 hasBestOaLocation W20160692811 @default.
• W2016069281 hasConcept C126322002 @default.
• W2016069281 hasConcept C141071460 @default.
• W2016069281 hasConcept C179755657 @default.
• W2016069281 hasConcept C2776376669 @default.
• W2016069281 hasConcept C2778063415 @default.
• W2016069281 hasConcept C2779541074 @default.
• W2016069281 hasConcept C2779609443 @default.
• W2016069281 hasConcept C2779978075 @default.
• W2016069281 hasConcept C2908647359 @default.
• W2016069281 hasConcept C2911091166 @default.
• W2016069281 hasConcept C71924100 @default.
• W2016069281 hasConcept C99454951 @default.
• W2016069281 hasConceptScore W2016069281C126322002 @default.
• W2016069281 hasConceptScore W2016069281C141071460 @default.
• W2016069281 hasConceptScore W2016069281C179755657 @default.
• W2016069281 hasConceptScore W2016069281C2776376669 @default.
• W2016069281 hasConceptScore W2016069281C2778063415 @default.
• W2016069281 hasConceptScore W2016069281C2779541074 @default.
• W2016069281 hasConceptScore W2016069281C2779609443 @default.
• W2016069281 hasConceptScore W2016069281C2779978075 @default.
• W2016069281 hasConceptScore W2016069281C2908647359 @default.
• W2016069281 hasConceptScore W2016069281C2911091166 @default.
• W2016069281 hasConceptScore W2016069281C71924100 @default.
• W2016069281 hasConceptScore W2016069281C99454951 @default.
• W2016069281 hasIssue "10" @default.
• W2016069281 hasLocation W20160692811 @default.
• W2016069281 hasLocation W20160692812 @default.
• W2016069281 hasLocation W20160692813 @default.
• W2016069281 hasOpenAccess W2016069281 @default.
• W2016069281 hasPrimaryLocation W20160692811 @default.
• W2016069281 hasRelatedWork W113810927 @default.
• W2016069281 hasRelatedWork W1904694489 @default.
• W2016069281 hasRelatedWork W1998866815 @default.
• W2016069281 hasRelatedWork W2050859124 @default.
• W2016069281 hasRelatedWork W2267962822 @default.
• W2016069281 hasRelatedWork W2272732540 @default.
• W2016069281 hasRelatedWork W2288548373 @default.
• W2016069281 hasRelatedWork W2340964262 @default.
• W2016069281 hasRelatedWork W2410261729 @default.
• W2016069281 hasRelatedWork W40023729 @default.
• W2016069281 hasVolume "71" @default.
• W2016069281 isParatext "false" @default.
• W2016069281 isRetracted "false" @default.

• next